Send Inquiry

Request To Call Back

Sirolimus-eluting coronary stents

Name: Sirolimus-eluting coronary stents
Brand: Advin Health Care
Price: 200 USD
Availability: InStock

Price 200 USD ($)/ Piece

Get a Price/Quote

MOQ : 1 Piece

Sirolimus-eluting coronary stents Specification

Measurement Range
Stent diameter: 2.5 mm to 4.0 mm; Stent length: 8 mm to 40 mm

Accuracy
High Placement Precision Under Angiography Guidance

Function
Revascularization of Blocked Coronary Arteries

Shelf Life
3 Years

Features
Biocompatible, Flexible Design, High Radial Strength, Thin Struts

Instruments Type
Implantable Medical Device

Storage Instructions
Store in a Cool, Dry Place

Usage Type
Disposable

Equipment Type
Coronary Stent

Material
Cobalt Chromium Alloy

Condition
New, Sterile

Technology
Sirolimus-Eluting Drug Coated

Portable
Yes, Single-use Packaging

Wall Mounted
No

Real-Time Operation
Yes

Noise Level
Silent

Operating Type
Manual Deployment

Use
Interventional Cardiology - Treatment of Coronary Artery Disease

Dimension (L*W*H)
Stent diameter: 2.5-4.0 mm, Length: 8-40 mm (varies by model)

Weight
Lightweight (<1 gram per stent)

Color
Metallic Silver

Balloon Compatibility
Compatible with PTCA Balloons

Packaging
Sterile, Individual Blister Pack

Drug Release Kinetics
Controlled, Sustained up to 30 days

Expansion System
Balloon-Expandable

Radiopacity
Excellent for Fluoroscopic Visualization

Marker Bands
Radio-Opaque, Platinum-Iridium

Crimped Delivery Diameter
0.014 inch guidewire compatibility

Polymer Type
Biostable or Biodegradable Polymer Coating

About Sirolimus-eluting coronary stents

Sirolimus-eluting coronary stents are designed to support long-term vessel patency by controlling excessive tissue growth within the artery. The controlled drug release helps improve healing while maintaining adequate blood flow to the heart muscle. Advin Health Care manufactures these stents with a strong focus on clinical reliability, safety, and consistent performance standards. These stents are widely used in interventional cardiology to support effective treatment of coronary artery disease and improve procedural outcomes.

Advanced Features

Sirolimus drug coating to help reduce restenosis

Designed for controlled and uniform drug release
Supports optimal vessel support after implantation
Compatible with standard coronary stent delivery systems

Certifications

We are certified with CE, ISO 13485, and ISO 9001 standards.

Product Keywords

Sirolimus-Eluting Coronary Stents, Drug-Eluting Stent (DES), Coronary Artery Stent, Anti-Restenosis Stent, Interventional Cardiology

U 1Ua UaU UUUU UU3UUUUUU3 U 1Ua U UU (DES) 1Ua U UU UaU 1Ua U UaUU U UU UaU UUU Ua UU

34N3412N12N NN12NN N N N34 14NN3414, NN12NN N oNNN21212N14 34oNNN 14 (DES), o34N3412N12N NNN N12N NN12NN, 12N NNN1234N NNo NN12NN, 12NN212N 341212N oN 34343 N

Stents coronarios liberadores de sirolimus, stent liberador de fArmacos (SLF), stent de arteria coronaria, stent antirreestenosis, cardiologAa intervencionista

Stents coronaires A Alution de sirolimus, stent A Alution de mAdicament (DES), stent de l'artA re coronaire, stent anti-restAnose, cardiologie interventionnelle

Superior Drug Delivery Technology

Utilizing Sirolimus and advanced polymer coatings, this coronary stent ensures a controlled and sustained drug release profile for up to 30 days. This approach minimizes restenosis risk by providing a consistent therapeutic effect directly at the arterial site, supporting enhanced vessel healing and reducing the likelihood of repeat procedures.

High Precision and Safety in Deployment

Engineered with platinum-iridium radio-opaque marker bands and excellent radiopacity, the stent provides outstanding fluoroscopic visibility. The result is high precision during angiography-guided placement, ensuring accuracy and safety even in complex coronary anatomies. Balloon-expandable technology enhances operator control during deployment.

Versatility and User-Friendly Design

Available in multiple diameters and lengths, this stent supports a broad range of clinical applications. Compatible with standard 0.014-inch guidewires and PTCA balloons, its flexible, lightweight design allows for easy maneuvering and optimal conformity to vessel walls, making it suitable for diverse patient profiles.

FAQ's of Sirolimus-eluting coronary stents:

Q: How does the sirolimus-eluting stent provide controlled drug release?

A: The stent is coated with a biostable or biodegradable polymer that allows for sustained and controlled release of sirolimus over up to 30 days. This ensures a consistent local therapeutic effect to reduce restenosis.

Q: What types of procedures is this coronary stent designed for?

A: This stent is intended for use in interventional cardiology, specifically for the revascularization of blocked coronary arteries in patients with coronary artery disease.

Q: When is the optimal time to use this Sirolimus-eluting stent during treatment?

A: The stent is deployed during a percutaneous coronary intervention (PCI) procedure, typically after a balloon angioplasty to restore proper blood flow in narrowed or blocked coronary arteries.

Q: Where can this stent be used, and what equipment is it compatible with?

A: It is utilized in catheterization laboratories and is compatible with PTCA balloons and 0.014-inch guidewires, fitting into standard interventional workflows.

Q: What is the deployment process for this device?

A: The stent is manually deployed over a guidewire and expanded with an angioplasty balloon at the lesion site. Its platinum-iridium markers provide excellent visibility to guide precise placement under fluoroscopy.

Q: What benefits does this stent offer to patients and clinicians?

A: Benefits include controlled drug release for reduced restenosis, excellent placement accuracy under angiography, superior vessel conformability due to its flexible design, and a broad range of size options to match patient anatomy.

Q: What storage and shelf life instructions should be followed for this coronary stent?

A: The stent should be stored in a cool, dry place and used before the expiration date (three years from manufacture). Each device comes in sterile, individual blister packaging for single-use applications.

Tell us about your requirement